ResearchLiver fibrosis risk, missed follow-up, and inequitable specialist referral in the All of Us Research Program: a retrospective cohort study
Research2017-P: Acceptability of T1D-CATCH: A Type 1 Diabetes (T1D) Specialty Community Health Worker (CHW) Model
Research1427-P: Fibrosis-4 Index Is Associated with ASCVD Burden, MACE, and Mortality in Real-World Type 2 Diabetes Cohort
ResearchTHU-040 Healthcare provider perspectives on mental health in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: the role of multidisciplinary teams and sex differences
ResearchAwareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among primary care providers in the four most populous U.S. cities.
ResearchFrom Guidelines to Practice: Case-Based Teaching Module to Improve MASLD Screening in Diabetes Care for Internal Medicine Residents.
ResearchBest buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study.
May 6, 2025Journal ArticleAwareness of metabolic dysfunction-associated steatotic liver disease (MASLD) in 4 major cities in the United States.Written by 1 Roon author & 16 others Via Hepatology Communications
ResearchHow much time do internal medicine residents spend on self-directed learning and on which resources: a multi-center study.
ResearchCost of Metabolic Dysfunction-Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six Countries.